Mechanism of hyperbaric oxygen therapy

Reading File

Hyperbaric oxygen therapy (HBOT) works by delivering 100% oxygen at pressures above 1 atmosphere absolute (ATA), which dramatically increases dissolved oxygen in plasma and tissues beyond what hemoglobin alone can carry. The core mechanisms include hyperoxia-driven tissue oxygenation, vasoconstriction that paradoxically reduces edema, and enhanced antimicrobial/wound-healing effects.

Searching sources...

Finding Sources

Searching PubMed

"hyperbaric oxygen therapy" AND mechanism

Good results. Now let me read the most authoritative sections in parallel - Guyton (physiology), Sabiston (surgical), and Campbell's Operative Orthopaedics.

Reading File

Good content from Guyton and Sabiston. Let me also read the Rockwood/Green section and do a paragraph search for more mechanism details (ROS, vasoconstriction, CO poisoning).

Reading File

Finding Sources

Excellent. Now let me read the Tintinalli's Emergency Medicine section which has a comprehensive mechanism description, and also get the Sabiston block 10 content:

Reading File

Let me read the rest of the Sabiston block 10 content and also get the Tintinalli HBOT section fully:

Reading File

I now have comprehensive content from multiple authoritative textbooks. Let me compile the full answer.

Mechanism of Hyperbaric Oxygen Therapy (HBOT)

What It Is

HBOT involves breathing 100% oxygen in a sealed chamber pressurized to 1.9 to 3.0 atmospheres absolute (ATA). The hyperbaric chamber is the delivery system, and oxygen is the drug. - Sabiston Textbook of Surgery, p. 917

Core Physical Principle: Henry's Law

At normal pressure, nearly all blood oxygen is carried by hemoglobin (which is ~97-98% saturated at sea level). Physically dissolved oxygen in plasma is negligible (~0.3 mL/dL). Under hyperbaric conditions, Henry's Law states that gas dissolves in liquid proportionally to its partial pressure. At 2-3 ATA breathing 100% O2:

Plasma pO2 rises to 1,000-2,000 mmHg (vs. ~100 mmHg normally)
Physically dissolved oxygen in plasma increases dramatically, enough to supply all tissue metabolic requirements even without hemoglobin
Tissue pO2 increases 10-fold compared to room air breathing
This elevated tissue oxygen level lasts 2-4 hours after the session ends - Sabiston, p. 917; Guyton & Hall Textbook of Medical Physiology

Mechanisms of Action

1. Hyperoxygenation and Expanded Diffusion Radius

The massively increased plasma oxygen creates a supraphysiologic PaO2 that expands the radius of oxygen diffusion from capillaries into tissues. This is especially important in:

Hypoxic wounds (where pO2 < 30 mmHg significantly impairs fibroblast proliferation, collagen synthesis, and epithelialization)
Ischemic zones where microvascular disruption has reduced local oxygen delivery - Rockwood & Green's Fractures in Adults, p. 714; Sabiston, p. 916

2. Paradoxical Vasoconstriction with Net Benefit

HBOT causes hyperoxic vasoconstriction, reducing blood flow by 10-20%. This sounds counterproductive, but it is beneficial because:

Edema is reduced (less fluid leaking from capillaries into interstitium)
Despite lower flow, oxygen delivery per unit volume of blood remains very high due to the enormously increased dissolved O2
Net effect: tissue edema decreases while tissue oxygen delivery increases - Tintinalli's Emergency Medicine, p. 76; Dermatology 2-Volume Set

3. Angiogenesis and NO Synthase Induction

The period of relative re-oxygenation following HBOT triggers a cycle of vascular growth:

Stimulates endothelial cell nitric oxide synthase (eNOS) synthesis
Promotes angiogenesis - formation of new capillary networks into hypoxic tissue
Encourages granulation tissue formation
Normalizes cutaneous microvascular reflexes - Sabiston, p. 917

4. Enhanced Wound-Healing Cellular Functions

High-tissue pO2 directly activates repair processes:

Fibroblast proliferation and function
Collagen synthesis (oxygen is a required cofactor for prolyl and lysyl hydroxylase enzymes)
Leukocyte bactericidal activity - neutrophil killing via oxidative burst requires oxygen; leukocytes are ineffective at pO2 < 30 mmHg
Stem cell proliferation - animal studies show increased stem cell activity and upregulated angiogenic signaling - Sabiston, p. 917-918

5. Reactive Oxygen Species (ROS) as Signaling Molecules

While high-dose ROS cause oxygen toxicity, physiologically modulated ROS from HBOT:

Increase proinflammatory cytokines that initiate tissue repair
Promote matrix synthesis
Modulate the wound-healing cascade at the molecular level
Act as a "stabilizing force that restores physiologic balance" at the tissue level - Sabiston, p. 917

6. Antimicrobial Mechanisms

Three distinct antibacterial effects:

Direct oxidative killing: ROS generated at high pO2 are directly bactericidal (the same free radicals responsible for O2 toxicity kill anaerobic bacteria)
Anaerobic organism suppression: Anaerobes (especially Clostridium species causing gas gangrene) stop growing when tissue pO2 exceeds ~70 mmHg - a condition HBOT readily achieves
Leukocyte potentiation: Neutrophil oxidative burst is oxygen-dependent; HBOT restores leukocyte killing capacity in previously hypoxic tissue - Guyton & Hall Medical Physiology; Sabiston, p. 917

7. Bubble Reduction (Decompression / Gas Embolism)

For decompression sickness and arterial gas embolism, HBOT works through physical compression:

Boyle's Law: higher pressure physically compresses nitrogen bubbles, reducing their volume and diameter
100% O2 breathing creates a maximum diffusion gradient for nitrogen to leave the bubble and diffuse out of tissue
Nitrogen is replaced with oxygen, which is metabolized, allowing the bubble to resolve

8. Carbon Monoxide Displacement

CO has ~240x the affinity of O2 for hemoglobin (forming carboxyhemoglobin, HbCO). HBOT accelerates CO elimination:

At 1 ATA breathing room air: HbCO half-life ~5 hours
At 1 ATA breathing 100% O2: half-life ~60-90 minutes
At 2.5-3 ATA with 100% O2: half-life ~20-30 minutes
HBOT also addresses CO toxicity in mitochondrial cytochrome oxidase (where CO binds and blocks cellular respiration), and prevents delayed neuropsychological sequelae - Morgan & Mikhail's Clinical Anesthesiology; Sabiston, p. 916

Summary of Mechanisms by System

Mechanism	Effect	Clinical Target
Increased dissolved O2 in plasma	10x tissue pO2	Hypoxic wounds, ischemia
Hyperoxic vasoconstriction	Reduced edema, maintained O2 delivery	Crush injury, post-op edema
eNOS induction + angiogenesis	New vessel growth	Chronic wounds, radiation injury
Leukocyte potentiation + direct ROS bactericidal	Enhanced killing of anaerobes	Gas gangrene, necrotizing fasciitis, osteomyelitis
Bubble compression (Boyle's Law) + N2 washout	Bubble resolution	Decompression sickness, air embolism
Competitive O2 displacement of CO	Faster HbCO clearance	CO poisoning
Stem cell/fibroblast/collagen activation	Accelerated tissue repair	Diabetic ulcers, osteoradionecrosis

Dosing Parameters

Pressure: 1.9 to 3.0 ATA (typically 2.0-2.4 ATA for most wound indications)
Duration: 90 to 120 minutes per session
Frequency: Once daily, 5-6 times per week
Course: Improvement expected after 15-20 treatments
Monitoring: Transcutaneous pO2 (TcPO2) - a wound TcPO2 < 35 mmHg indicates hypoxic wound; in-chamber TcPO2 ≥ 200 mmHg predicts likely benefit - Sabiston, p. 917

Recognized Clinical Indications

Decompression sickness, arterial gas embolism, carbon monoxide poisoning, gas gangrene (Clostridium myonecrosis), necrotizing fasciitis, chronic diabetic foot ulcers, osteoradionecrosis, refractory osteomyelitis, crush injuries, compromised flaps/grafts, acute thermal burns, and radiation-induced wounds. - Sabiston Textbook of Surgery; Guyton & Hall

Complications

Barotrauma: Middle ear barotrauma (most common), sinus barotrauma, pneumothorax (rare but life-threatening)
O2 toxicity - CNS: Grand mal seizures (Paul Bert effect)
O2 toxicity - Pulmonary: From tracheobronchitis to ARDS (Lorrain-Smith effect)
Ophthalmologic: Transient myopia, hyperopia
Hypoglycemia: Particularly in diabetic patients
Absolute contraindications: Uncontrolled pneumothorax; concurrent bleomycin or doxorubicin therapy; disulfiram therapy - Sabiston, p. 918

This is a shared conversation. Sign in to Orris to start your own chat.